ONS Chemotherapy Immunotherapy Certificate terms

ONS Chemotherapy Immunotherapy Certificate terms Define neoadjuvant therapy -Definition-Treatment is given prior to surgery to shrink the tumor Define adjuvant therapy -Definition-Additional cancer treatment given after the primary treatment to lower the risk that the cancer reoccur 3 subcategories of alkylating agents: -Definition-1. Nitrogen mustards 2. Platinum-based agents (do not possess an alkyl group but still termed alkylating agents as they work similarly) 3. Nitrosoureas Common alkylating agents: -Definition-Cyclophosphamide (Cytoxan) Ifosfamide (Ifex) Bendamustine (Treanda) Common platinum-based agents: -Definition-Cisplatin (Platinol) Carboplatin (Paraplatin) What is unique about nitrosoureas agents? -Definition-Able to cross the blood-brain barrier; can be effective in treating some brain tumors Common nitrosoureas agents: -Definition-Carmustine (BiCNU) Lomustine (CeeNu) Streptozocin (Zanosar) Hypersensitivity can occur with late doses of: -Definition-Carboplatin These agents are typically categorized as highly emetogenic: -Definition-1. Alkylating agents